The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Liver metastases from colorectal cancer. Different strategies and outcomes

På svenska

Author

Summary, in English

Patients with colorectal liver metastases (CRLM) increasingly undergo liver resections. The belief is that the resection or ablation of a tumor, when possible, is the only possibility of a cure. The classical strategy is where the primary colorectal tumor is resected as the first intervention, followed by resection of the liver metastasis at a second stage. The liver-first strategy is where preoperative chemotherapy is given, followed by resection of the liver metastases and then resection of the colorectal primary tumor at a second stage. The third option is the simultaneous strategy where the patient undergoes both liver and primary tumor resection during the same operation. The patient selection and drop-out from the planned intervention are poorly known. None of the three strategies have demonstrated any clear advantage or disadvantage in terms of survival. A repeated hepatectomy, for patients with recurrent CRLM, is increasingly performed with mostly unknown postoperative functional liver volume (FLV).
Specific aims to investigate:
I. Why do patients scheduled for the liver-first strategy not complete both the planned liver and primary resections?
II. Compare the liver-first to the classical strategy for patients presenting with synchronous CRLM (sCRLM).
III. Compare the simultaneous strategy with the classical strategy for patients presenting with sCRLM, focusing on patients undergoing major liver resections.
IV. Measure liver regeneration and survival data after a repeated liver procedure (resection or ablation) for recurrent CRLM.
Results and conclusions:
I. Up to 35% of patients with sCRLM do not complete the planned treatment.
II. The liver-first and the classical strategy did not show any overall survival difference.
III. Simultaneous resections appeared to have more complications, shorter total length-of-stay but similar overall survival as patients chosen for the classical strategy.
IV. We found a small change in FLV after two hepatic procedures but with a considerable inter-individual variation. Patients selected for a repeated hepatic procedure for recurrent CRLM had an acceptable survival.
When choosing different strategies for sCRLM patients, our results imply that we should select according to treatment logistics, tumor symptoms, and surgical feasibility. When patients present with recurrent CRLM, a high variance in liver volume after repeated resection can be expected when planning future repeated resections.

Department/s

Publishing year

2019

Language

English

Publication/Series

Lund University, Faculty of Medicine Doctoral Dissertation Series

Volume

2019

Issue

122

Document type

Dissertation

Publisher

Lund University, Faculty of Medicine

Topic

  • Surgery

Keywords

  • Liver metastases
  • Colorectal Neoplasms
  • Hepatectomy
  • Mortality
  • Treatment outcome
  • Retrospective studies
  • Sweden
  • Registries
  • Volume measurements
  • Repeat hepatectomy
  • liver surgery
  • Functional liver volume
  • Repeated operation
  • Recurrence

Status

Published

ISBN/ISSN/Other

  • ISSN: 1652-8220
  • ISBN: 978-91-7619-851-3

Defence date

13 December 2019

Defence time

13:00

Defence place

Segerfalksalen, BMC A10, Sölvegatan 17 i Lund

Opponent

  • Bjørn Atle Bjørnbeth (PhD)